Clinicopathological impact of VEGFR2 and VEGF-C in patients with EGFR-major mutant NSCLC receiving osimertinib

論文 Clinicopathological impact of VEGFR2 and VEGF-C in patients with EGFR-major mutant NSCLC receiving osimertinib

著者 Kaira K, Imai H, Mouri A, Hashimoto K, Miura Y, Shiono A, Yamaguchi O, Kobayashi K, Kawasaki T, Yasuda M, Kagamu H.